Get started
MarketMoversReport

Intercept Announces Positive Data in Fibrosis due to NASH

Long
MarketMoversReport  
NASDAQ:ICPT   None
Beyond Technical Analysis
0
0
beyondta
ICPT: Intercept Pharmaceuticals, Inc.
2022-07-07 07:30:00
Intercept Announces Positive Data in Fibrosis due to NASH from a New Analysis of its Phase 3 REGENERATE Study of Obeticholic Acid (OCA)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.